In Vitro Inhibition of Human Immunodeficiency Virus Type‐1 (HIV‐1) Reverse Transcriptase by Gold(III) Porphyrins

No abstract is available for this paper.

• Publication year

  2004

• Venue

  ChemBioChem

• Publication date

  2004-09-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/cbic.200300773PMID 15368585
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nitrido-ruthenium(VI) and -osmium(VI) complexes of multianionic chelating (N, O) ligands. Reactions with nucleophiles, electrophiles and oxidizing agents

  2003cited by this paper
• Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells.

  2003cited by this paper
• Syntheses and Characterization of Gold(III) Tetradentate Schiff Base Complexes. X-ray Crystal Structures of [Au(sal2pn)]Cl·2.5H2O and [Au(sal2en)]PF6

  2001cited by this paper
• Facile nucleophilic addition to salophen coordinated to nitridoosmium(VI).

  2001cited by this paper
• The Connection Domain Is Implicated in Metalloporphyrin Binding and Inhibition of HIV Reverse Transcriptase*

  1999cited by this paper
• Gold-based therapeutic agents.

  1999cited by this paper
• Metalle in der Medizin

  1999cited by this paper
• Gold-Based Therapeutic Agents

  1999cited by this paper
• Metals in Medicine.

  1999cited by this paper
• Nitrido-ruthenium(VI) and -osmium(VI) complexes containing chelating multianionic (N, O) ligands. Synthesis, crystal structures and reactions with triphenylphosphine

  1998cited by this paper
• Nitrogen Transfer from a Nitridomanganese(V) Complex: Amination of Silyl Enol Ethers

  1996cited by this paper
• Inhibition of human immunodeficiency virus-1 reverse transcriptase by heme and synthetic heme analogs.

  1996cited by this paper
• Treatment of HIV associated psoriatic arthritis with oral gold.

  1996cited by this paper
• Novel luminescent cyclometaiated and terpyridine gold(III) complexes and DNA binding studies

  1995cited by this paper
• Spectroscopic properties and crystal structure of a gold(III) amide complex: [Au(HL)(Cl2] (H2L = 2,2′-bis(2-pyridylcarboxyamide)-1,1′-binaphthyl)

  1994cited by this paper
• DNA binding studies and site selective fluorescence sensitization of an anthryl probe

  1993cited by this paper
• A new method for measuring reverse transcriptase activity by ELISA.

  1992cited by this paper
• Catalytic antibodies. Circular dichroism and UV-vis studies of antibody-metalloporphyrin interactions

  1992cited by this paper
• Complexes of gold(III) with mononegative bidentate N,O-ligands

  1992cited by this paper
• AN APPROACH TO CHIRAL METAL CATALYSTS ; THE SYNTHESIS AND X-RAY CRYSTAL STRUCTURES OF A CHIRAL TETRADENTATE BINAPHTHYL BIS-AMIDE LIGAND AND ITS OSMIUM (VI)-OXO DERIVATIVE

  1991cited by this paper
• Synthesis and molecular structure of a nitridochromium(V) complex stabilized with dianionic organic amide ligand

  1988cited by this paper
• Synthesis and reactivities of trans-dioxoosmium(VI) Schiff-base complexes. X-ray crystal structure of dioxo[N,N′-(1,1,2,2-tetramethylethylene)bis(3-tert- butylsalicylidenaminato)]osmium(VI)

  1988cited by this paper
• Interactions of porphyrins with purified DNA and more highly organized structures.

  1988cited by this paper
• High-valent schiff-base complexes of osmium: X-ray crystal structure of trans-[OsIV(salen)(SPh)2]

  1986cited by this paper
• Synthesis and molecular structure of oxochromium(V) cations. Coordination with donor ligands

  1985cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Solution properties of nickel(II) tetra(4-N-methylpyridyl) porphine and the influence of acetone, pyridine and imidazole

  1974cited by this paper
• meso-Tetraphenylporphyrin purification

  1973cited by this paper
• A simplified synthesis for meso-tetraphenylporphine

  1967cited by this paper
• Inner Complex Chelates. I. Analogs of Bisacetylacetoneethylenediimine and its Metal Chelates1,2

  1955cited by this paper

• Zinc Complexes of Cationic Ammonium Phenyl and Methylpyridinium Porphyrins Display Synergistic Anti-HIV‑1 and Broad-Spectrum Antibacterial Activity

  2025cites this paper
• Fullerene (C60 & C70)‐Meso‐Tris‐4‐Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild‐Type and Drug‐Resistant HIV‐1 Clades B and C

  2025cites this paper
• Photodynamic inactivation of KPC-producing Klebsiella pneumoniae difficult-to-treat resistance (DTR) by a cationic porphyrin.

  2025cites this paper
• Exploring antiviral and antiparasitic activity of gold N-heterocyclic carbenes with thiolate ligands.

  2024cites this paper
• Porphyrins with combinations of 4-carboxyphenyl and 4-hydroxyphenyl substituents in meso-positions as anti-HIV-1 agents

  2024cites this paper
• Heteroleptic (S^C)-cyclometallated gold(III) complexes as novel antiviral agents

  2024cites this paper
• Two cationic meso-thiophenium porphyrins and their zinc-complexes as anti-HIV-1 and antibacterial agents under non-photodynamic therapy (PDT) conditions.

  2022cites this paper
• “Organometallic Chemistry of Gold-Based Drugs”

  2021cites this paper
• Novel Cationic Meso-Arylporphyrins and Their Antiviral Activity against HSV-1

  2021cites this paper
• Main Avenues in Gold Coordination Chemistry.

  2021cites this paper
• Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike‐ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics**

  2020cites this paper
• Porphyrin-Armored Gold Nanospheres Modulate the Secondary Structure of α-Synuclein and Arrest Its Fibrillation

  2020cites this paper
• Synthesis, characterization and biological activity of bromido[3-ethyl-4-aryl-5-(2-methoxypyridin-5-yl)-1-propyl-1,3-dihydro-2H-imidazol-2-ylidene]gold(i) complexes.

  2020cites this paper
• The Application of Porphyrins and Their Analogues for Inactivation of Viruses

  2020cites this paper
• The Application of Porphyrins and Their Analogues for Inactivation of Viruses.

  2020cites this paper
• What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks.

  2020cites this paper
• Antimicrobial activity and safety applications of meso-tetra(4-pyridyl)platinum(II) porphyrin.

  2019cites this paper
• Dual activity of amphiphilic Zn(II) nitroporphyrin derivatives as HIV-1 entry inhibitors and in cancer photodynamic therapy.

  2019cites this paper
• In vitro antitumor activity, metal uptake and reactivity with ascorbic acid and BSA of some gold(III) complexes with N,N'-ethylenediamine bidentate ester ligands.

  2017cites this paper
• Spectral properties and solution behavior of gold(III) coordination compounds with water-soluble porphyrins

  2016cites this paper
• Synthesis and Anticancer Activity of Water Soluble Porphyrin APPROVED BY SUPERVISING COMMITTEE:

  2015cites this paper
• Synthesis and anti-cancer activities of a water soluble gold(III) porphyrin.

  2015cites this paper
• From gold porphyrins to gold nanoparticles: catalytic nanomaterials for glucose oxidation.

  2014cites this paper
• Historical and biochemical aspects of a seventeenth century gold-based aurum vitae recipe

  2014cites this paper
• Selective binding and reverse transcription inhibition of single-strand poly(A) RNA by metal TMPyP complexes.

  2014cites this paper
• High-Technology Therapy Using Biomolecules or Synthetic Compounds for HIV Inhibition

  2013cites this paper
• Gold compounds with anti-HIV and immunomodulatory activity

  2012cites this paper
• Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives.

  2012cites this paper
• Modification of HIV-1 reverse transcriptase and integrase activity by gold(III) complexes in direct biochemical assays.

  2012cites this paper
• The evaluation of gold-based compounds as potential inhibitors of HIV-1 replication.

  2012cites this paper
• Exploring the mechanisms of metal-based pharmacological agents via an integrated approach.

  2012cites this paper
• New bis(thiosemicarbazonate) gold(III) complexes inhibit HIV replication at cytostatic concentrations: potential for incorporation into virostatic cocktails.

  2011cites this paper
• Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment.

  2011cites this paper
• Porphyrin complexes of the period 6 main group and late transition metals.

  2011cites this paper
• Gold compounds as therapeutic agents for human diseases.

  2011cites this paper
• Encapsulation of dual cytotoxic and anti-angiogenic gold(III) complexes by gelatin-acacia microcapsules: in vitro and in vivo studies.

  2010cites this paper
• HIV therapeutic possibilities of gold compounds

  2010cites this paper
• Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.

  2010cites this paper
• Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

  2009cites this paper
• The anti-cancer properties of gold(III) compounds with dianionic porphyrin and tetradentate ligands

  2009cites this paper
• DNA interactions and photocatalytic strand cleavage by artificial nucleases based on water-soluble gold(III) porphyrins

  2009cites this paper
• Porphyrinmaleimides: towards thiol probes for cysteine residues in proteins.

  2008cites this paper
• Luminescent Au(III) organometallic complex of N-confused tetraphenylporphyrin.

  2008cites this paper
• A porphyrin complex of Gold(I): (Phosphine)gold(I) azides as cation precursors

  2008cites this paper
• Structural, electrochemical, and spectroscopic properties of a class of dodecasubstituted iron porphyrins bearing four positive charges close to the metal

  2007cites this paper
• Targeting the mitochondrial cell death pathway with gold compounds

  2007cites this paper
• Anticancer Cyclometalated [AuIIIm(C∧N∧C)mL]n+ Compounds: Synthesis and Cytotoxic Properties

  2006cites this paper
• Gold(III) Salen complex-catalyzed synthesis of propargylamines via a three-component coupling reaction.

  2006cites this paper
• Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.

  2006cites this paper
• Gold(III) porphyrin-catalyzed cycloisomerization of allenones.

  2006cites this paper
• Halogenation of unactivated carbon centers in natural product biosynthesis: trichlorination of leucine during barbamide biosynthesis.

  2006cites this paper
• Physiologically stable vanadium(IV) porphyrins as a new class of anti-HIV agents.

  2005cites this paper
• Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells.

  2005cites this paper